CN106983797A - 一种具有补血功能的组合物及其制备方法 - Google Patents
一种具有补血功能的组合物及其制备方法 Download PDFInfo
- Publication number
- CN106983797A CN106983797A CN201610036143.7A CN201610036143A CN106983797A CN 106983797 A CN106983797 A CN 106983797A CN 201610036143 A CN201610036143 A CN 201610036143A CN 106983797 A CN106983797 A CN 106983797A
- Authority
- CN
- China
- Prior art keywords
- coarse powder
- fruit
- parts
- jujube
- donkey
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 22
- 210000004369 blood Anatomy 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 98
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 49
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 49
- 241000233866 Fungi Species 0.000 claims abstract description 49
- 244000241872 Lycium chinense Species 0.000 claims abstract description 49
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 49
- 240000000249 Morus alba Species 0.000 claims abstract description 49
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 49
- 108010010803 Gelatin Proteins 0.000 claims abstract description 48
- 239000008273 gelatin Substances 0.000 claims abstract description 48
- 229920000159 gelatin Polymers 0.000 claims abstract description 48
- 235000019322 gelatine Nutrition 0.000 claims abstract description 48
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 48
- 239000000843 powder Substances 0.000 claims description 119
- 241001247821 Ziziphus Species 0.000 claims description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000706 filtrate Substances 0.000 claims description 24
- 238000001914 filtration Methods 0.000 claims description 24
- 235000013312 flour Nutrition 0.000 claims description 23
- 229920002752 Konjac Polymers 0.000 claims description 22
- 239000004376 Sucralose Substances 0.000 claims description 21
- 235000019408 sucralose Nutrition 0.000 claims description 21
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 240000001417 Vigna umbellata Species 0.000 claims description 17
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 239000000287 crude extract Substances 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000012752 auxiliary agent Substances 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 235000013305 food Nutrition 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 238000007670 refining Methods 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 235000013402 health food Nutrition 0.000 claims 1
- 230000007812 deficiency Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 3
- -1 flavouring Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007887 hard shell capsule Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000005548 health behavior Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有补血养血功能的组合物及其制备方法。该组合物是由阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳按一定重量配比制备而成,它可以被制成任何一种常用制剂,优选口服制剂。该组合物具有补血养血的功效,能明显改善人体血虚症状,增强体质。
Description
技术领域
本发明涉及一种具有补血功能的组合物及其制备方法,属于食品的技术领域。
背景技术
血虚,是指体内阴血亏损的病理现象。可由失血过多,或久病阴血虚耗,或脾胃功能失常,水谷精微不能化生血液等所致。血虚主症为面色萎黄、眩晕、心悸、失眠、脉虚细等。血虚之体的一般表现是这样的:1、经常疲劳是贫血最常见的症状,甚至贫血严重的时候还会在疲倦中出现低烧。2、运动之后心慌、气短最为常见,一些严重的贫血者还会出现心绞痛和心力衰竭。3、头痛、头晕、目眩、耳鸣,注意力不集中,失眠。严重的贫血者可出现神志模糊等症状。4、没有食欲、腹胀、恶心。5、皮肤干燥发黄,头发干枯没有光泽,有瘀斑或瘀点等。进补宜采用补血、养血、生血之法。
食疗是中国人的传统习惯,通过饮食达到调理身体,强壮体魄的目的。食疗文化源远流长,食疗是一种长远的养生行为,是一种健康的健体之道。
目前市场上补血养血的食疗产品效果均不太显著,存在携带引用不方便或者人体摄取量少等不足,因此,有必要根据中医的药食同源理论和食疗养生理论,研制出一种适合人们需要的食用方便的新型功能性补血养血的食疗产品。
发明内容
本发明主要解决的技术问题是提供一种具有补血养血功能的组合物;本发明还提供了该组合物的制备方法。
本发明是通过以下技术方案实现的:
本发明是由下述重量份的组分制成的:
阿胶2-20份、大枣80-180份、桑椹80-180份、枸杞子80-180份、龙眼肉50-120份、黑木耳30-100份。
优选为:
阿胶5-15份、大枣110-130份、桑椹110-130份、枸杞子110-130份、龙眼肉70-90份、黑木耳50-70份。
进一步优选为:
阿胶10份、大枣120份、桑椹120份、枸杞子120份、龙眼肉80份、黑木耳60份。
本发明涉及一种组合物,它是在现有中医理论的基础上,进行科学配伍,发挥组分之间相互协同的作用,从而筛选出能补血养血的组方。其中,阿胶补血滋阴,润燥,止血,用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。大枣味甘性温、归脾胃经,有补中益气、养血安神、缓和药性的功能,现代的药理学发现,大枣含有蛋白质、脂肪、糖类、有机酸、维生素A、维生素C、多种微量钙以及氨基酸等丰富的营养成份。桑椹具有补肝益肾、生津润燥、乌发明目等功效,含有多种维生素,尤其是含有丰富的磷和铁,能益肾补血,使人面色红润。枸杞子滋补肝肾,益精明目,龙眼肉补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。黑木耳具有滋补、润燥、养血益胃、活血止血、润肺、润肠的作用。
本发明组合物的制备方法如下:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳直接粉碎得到粉末;或加水或不同浓度的乙醇提取,提取液浓缩干燥得粗提物;或进一步采用水提醇沉法、有机溶剂萃取法、柱层析法、二氧化碳超临界萃取法、水蒸气蒸馏法进行精制得到精提物;上述粉末或粗提物或精提物不加或者加入适量辅料,按常规工艺制备而成。
如可以制成常用的片剂(分散片、泡腾片、口腔崩解片、含片、咀嚼片、泡腾片)、胶囊剂(硬胶囊、软胶囊)、颗粒剂、丸剂(滴丸剂)、散剂等固体制剂形式,也可以制成糖浆、酒剂、酊剂、口服液等液体制剂形式。因此,该组合物中除有效成分外,还可以含有药学上可以接受的辅料。
这里所述的辅料,可以根据不同的制剂有所不同,如在片剂、胶囊剂、颗粒剂等固体制剂中常用的稀释剂、崩解剂、赋形剂、粘合剂、润滑剂、表面活性剂、填充剂、矫味剂等;在糖浆、口服液等液体制剂形式中常用的表面活性剂、稀释剂、防腐剂、稳定剂、矫味剂、增稠剂、助流剂等。
其常用辅料如淀粉、乳糖、蔗糖、三氯蔗糖、糊精、糖粉、微晶纤维素、甘露醇、木糖醇、聚乙二醇、硫酸钙、磷酸氢钙、碳酸钙、改良淀粉、山梨醇、聚乙烯吡咯烷酮、重质碳酸镁、羧甲基纤维素钠、羟丙甲基纤维素、甲基纤维素、乙基纤维素、羧甲淀粉钠、羟丙基纤维素、聚维酮K30、白陶土、预胶化淀粉、硬脂酸镁、滑石粉、微粉硅胶、甜叶菊苷、甜菜碱、阿司帕坦、甘草甜素、糖精钠、柠檬酸、酒石酸、冰糖、蜂蜜、牛奶香精、食用盐、荞麦粉、魔芋粉、燕麦粉、紫薯粉、红豆粉、绿豆粉、豆浆粉、气相二氧化硅等。
本发明组合物的制备方法如下:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加水提取,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量辅料,混匀,即得。
优选的制备方法如下:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加6-15倍量水提取1-4次,每次1-4小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量助剂、矫味剂,混匀,即得。
其中,助剂是指荞麦粉、魔芋粉、燕麦粉、紫薯粉、红豆粉中的一种或一种以上;矫味剂是指蔗糖、三氯蔗糖、柠檬酸、酒石酸、牛奶香精、食用盐中的一种或一种以上。
更优选的制备方法如下:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加8-12倍量水提取1-3次,每次1-3小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
本发明组合物的制备方法还可以为:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加6-15倍量50-90%乙醇提取1-4次,每次1-4小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,干燥,粉碎,加入适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
本发明组合物的制备方法还可以为:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加6-15倍量水提取1-4次,每次1-4小时,过滤,合并滤液,减压浓缩至稠膏,干燥,粉碎,加入适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
本发明组合物的制备方法还可以为:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加8-12倍量50-90%乙醇提取1-3次,每次1-3小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
本发明组合物袋泡茶的制备方法如下:
将所述重量份的阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳直接粉碎得到粉末,包装,即得。
以下通过实施例形式的具体实施方式,对本发明的上述内容作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实施例。凡基于本发明上述内容所实现的技术均属于本发明的范围。
具体实施方式
实施例1
阿胶10g、大枣120g、桑椹120g、枸杞子120g、龙眼肉80g、黑木耳60g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加10倍量水提取2次,每次2小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例2
阿胶15g、大枣110g、桑椹130g、枸杞子110g、龙眼肉90g、黑木耳50g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加10倍量水提取2次,每次2小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例3
阿胶5g、大枣130g、桑椹110g、枸杞子130g、龙眼肉70g、黑木耳70g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加10倍量水提取2次,每次2小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例4
阿胶20g、大枣80g、桑椹180g、枸杞子80g、龙眼肉120g、黑木耳30g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加12倍量水提取1次,提取3小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例5
阿胶2g、大枣180g、桑椹80g、枸杞子180g、龙眼肉50g、黑木耳100g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加8倍量水提取3次,每次1小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量荞麦粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例6
阿胶12g、大枣150g、桑椹125g、枸杞子125g、龙眼肉75g、黑木耳55g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加15倍量水提取2次,每次1小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量燕麦粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例7
阿胶8g、大枣115g、桑椹115g、枸杞子115g、龙眼肉85g、黑木耳65g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加6倍量水提取4次,每次1.5小时,过滤,合并滤液,减压浓缩至稠膏,干燥,粉碎,加入适量燕麦粉、蔗糖、三氯蔗糖,混匀,即得。
实施例8
阿胶18g、大枣100g、桑椹150g、枸杞子100g、龙眼肉100g、黑木耳40g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加10倍量70%乙醇提取2次,每次2小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,干燥,粉碎,加入适量红豆粉、燕麦粉、魔芋粉、三氯蔗糖,混匀,即得。
实施例9
阿胶3g、大枣150g、桑椹100g、枸杞子150g、龙眼肉60g、黑木耳80g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加12倍量90%提取2次,每次1小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量燕麦粉、魔芋粉、蔗糖、柠檬酸,混匀,即得。
实施例10
阿胶9g、大枣140g、桑椹90g、枸杞子140g、龙眼肉100g、黑木耳40g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加8倍量50%乙醇提取3次,每次1小时,过滤,合并滤液,减压浓缩至稠膏,干燥,粉碎,加入适量燕麦粉、魔芋粉、酒石酸、三氯蔗糖,混匀,制粒,干燥,装胶囊,即得。
实施例11
阿胶14g、大枣150g、桑椹100g、枸杞子150g、龙眼肉60g、黑木耳90g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加10倍量水提取2次,每次2小时,过滤,合并滤液,减压浓缩至稠膏,加入适量荞麦粉、魔芋粉、蔗糖、三氯蔗糖,混匀,制粒,干燥,压片,即得。
实施例12
阿胶16g、大枣170g、桑椹85g、枸杞子170g、龙眼肉75g、黑木耳55g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加8倍量水提取3次,每次1小时,过滤,合并滤液,减压浓缩至稠膏,加入适量红豆粉、魔芋粉、食用盐,混匀,加水至全量,即得。
实施例13
阿胶10g、大枣120g、桑椹120g、枸杞子120g、龙眼肉80g、黑木耳60g
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳直接粉碎成粉末,包装,即得。
实施例14
阿胶10g、大枣120g、桑椹120g、枸杞子120g、龙眼肉80g、黑木耳60g
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加10倍量70%乙醇提取2次,每次2小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
以上均为本发明较佳的实现方案,除此之外,本发明还可以其他实现方式,需要说明的是,在没有脱离本发明发明构思的前提下,任何显而易见的替换均在本发明保护范围之内。
经人体试食本发明组合物显示,本发明组合物能显著提高体质,改善血虚症状,提示本发明组合物能补血养血,增强体质。
Claims (10)
1.一种具有补血功能的组合物,其特征在于,它是由下列重量份的组分组成:阿胶2-20份、大枣80-180份、桑椹80-180份、枸杞子80-180份、龙眼肉50-120份、黑木耳30-100份。
2.根据权利要求1所述的组合物,其特征在于,它是由下列重量份的组分组成:阿胶5-15份、大枣110-130份、桑椹110-130份、枸杞子110-130份、龙眼肉70-90份、黑木耳50-70份。
3.权利要求1或2所述组合物的制备方法,其特征在于,它是这样制备的:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳直接粉碎得到粉末;或加水或不同浓度的乙醇提取,提取液浓缩干燥得粗提物;或进一步采用水提醇沉法、有机溶剂萃取法、柱层析法、二氧化碳超临界萃取法、水蒸气蒸馏法进行精制得到精提物;上述粉末或粗提物或精提物不加或者加入适量辅料,按常规工艺制备而成。
4.根据权利要求3所述的制备方法,其特征在于,它是这样制备的:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加水提取,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量辅料,混匀,即得。
5.根据权利要求4所述的制备方法,其特征在于,它是这样制备的:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加6-15倍量水提取1-4次,每次1-4小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量助剂、矫味剂,混匀,即得。
6.根据权利要求5所述的制备方法,其特征在于,所述的助剂是指荞麦粉、魔芋粉、燕麦粉、紫薯粉、红豆粉中的一种或一种以上;矫味剂是指蔗糖、三氯蔗糖、柠檬酸、酒石酸、牛奶香精、食用盐中的一种或一种以上。
7.根据权利要求5或6所述的制备方法,其特征在于,它是这样制备的:
将阿胶粉碎成粗粉,得粗粉1,备用;将桑椹、龙眼肉粉碎成粗粉,得粗粉2,备用;将大枣、枸杞子、黑木耳加8-12倍量水提取1-3次,每次1-3小时,过滤,合并滤液,减压浓缩至稠膏,加入粗粉2,混匀,干燥,粉碎,加入粗粉1和适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
8.根据权利要求3所述的制备方法,其特征在于,它是这样制备的:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加6-15倍量水提取1-4次,每次1-4小时,过滤,合并滤液,减压浓缩至稠膏,干燥,粉碎,加入适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
9.根据权利要求3所述的制备方法,其特征在于,它是这样制备的:
将阿胶、大枣、桑椹、枸杞子、龙眼肉、黑木耳加6-15倍量50-90%乙醇提取1-4次,每次1-4小时,过滤,合并滤液,减压回收乙醇至无醇味,继续浓缩至稠膏,干燥,粉碎,加入适量红豆粉、魔芋粉、三氯蔗糖,混匀,即得。
10.权利要求1或2所述组合物用于制备具有养血、补血功能的食品或保健食品中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610036143.7A CN106983797A (zh) | 2016-01-20 | 2016-01-20 | 一种具有补血功能的组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610036143.7A CN106983797A (zh) | 2016-01-20 | 2016-01-20 | 一种具有补血功能的组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106983797A true CN106983797A (zh) | 2017-07-28 |
Family
ID=59413545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610036143.7A Pending CN106983797A (zh) | 2016-01-20 | 2016-01-20 | 一种具有补血功能的组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106983797A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107669813A (zh) * | 2017-11-17 | 2018-02-09 | 荣成奥汛海洋生物科技有限公司 | 一种改善贫血的双参嚼片及其制备方法 |
CN108420886A (zh) * | 2018-06-01 | 2018-08-21 | 哈福(荆门)健康管理有限公司 | 一种改善贫血的功能性组合物及其制备方法和应用 |
CN109090415A (zh) * | 2018-07-25 | 2018-12-28 | 安徽全康药业有限公司 | 一种补血益气人参阿胶冲饮 |
CN109567073A (zh) * | 2019-01-08 | 2019-04-05 | 广东海洋大学 | 一种富含血红蛋白的鱼血制品及其生产方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614369A (zh) * | 2011-01-26 | 2012-08-01 | 北京因科瑞斯医药科技有限公司 | 一种治疗心律失常的药物组合物及其制备方法 |
-
2016
- 2016-01-20 CN CN201610036143.7A patent/CN106983797A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614369A (zh) * | 2011-01-26 | 2012-08-01 | 北京因科瑞斯医药科技有限公司 | 一种治疗心律失常的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
宋敬东: "《一眼识病 一招救命 一术养病大全集》", 31 January 2014, 天津科学技术出版社 * |
崔钟雷: "《长寿保健大全》", 31 July 2008, 万卷出版公司 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107669813A (zh) * | 2017-11-17 | 2018-02-09 | 荣成奥汛海洋生物科技有限公司 | 一种改善贫血的双参嚼片及其制备方法 |
CN108420886A (zh) * | 2018-06-01 | 2018-08-21 | 哈福(荆门)健康管理有限公司 | 一种改善贫血的功能性组合物及其制备方法和应用 |
CN109090415A (zh) * | 2018-07-25 | 2018-12-28 | 安徽全康药业有限公司 | 一种补血益气人参阿胶冲饮 |
CN109567073A (zh) * | 2019-01-08 | 2019-04-05 | 广东海洋大学 | 一种富含血红蛋白的鱼血制品及其生产方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101919801B (zh) | 口腔吸收固体能量泡腾制剂 | |
KR20020087298A (ko) | 야생삼을 주성분으로 함유하는 자양강장용 조성물 | |
CN106983797A (zh) | 一种具有补血功能的组合物及其制备方法 | |
CN102772586A (zh) | 一种具有解酒、护肝功能的制剂及其制备方法 | |
KR20120123064A (ko) | 해바라기 추출물을 포함한 약학 조성물, 그의 제조 방법 및 용도 | |
CN1947757B (zh) | 地黄叶提取物及其制备方法和用途、用该提取物制备的药物 | |
CN102697982B (zh) | 一种具有辅助降血脂功能的组合物及其制备方法 | |
CN101970008B (zh) | 含有抗酸剂和唾液刺激剂的可口的固体组合物 | |
CN106983787A (zh) | 一种具有逐瘀功能的组合物及其制备方法 | |
CN107950929A (zh) | 一种具有改善睡眠功能的组合物及其制备方法和用途 | |
CN107224545A (zh) | 一种具有利湿功能的组合物及其制备方法 | |
CN107223959A (zh) | 一种具有滋阴功能的组合物及其制备方法 | |
CN106432385A (zh) | 一种高纯度灯盏花素提取物及制剂的制备方法及用途 | |
CN103005447B (zh) | 一种提高免疫力的保健食品组合物及其制备方法 | |
CN107223958A (zh) | 一种具有清火功能的组合物及其制备方法 | |
CN104815027A (zh) | 一种刺玫叶总黄酮提取物泡腾片及其制备方法 | |
CN104000181A (zh) | 一种用于缓解体力疲劳的组合物及其制备方法 | |
CN107223961A (zh) | 一种具有解酒保肝作用的组合物及其制备方法 | |
CN101190250B (zh) | 一种防治高原病的咀嚼片及其制备方法 | |
CN106615401A (zh) | 一种姜茶珍及制备方法 | |
CN112914008A (zh) | 一种气郁体质保健固体饮料及其制备方法 | |
CN105767718A (zh) | 一种具有祛黄褐斑功能的组合物及其制备方法 | |
CN102100902A (zh) | 四逆泡腾片 | |
CN107224562A (zh) | 一种具有补阳功能的组合物及其制备方法 | |
CN106983833A (zh) | 一种具有补气功能的组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170728 |
|
RJ01 | Rejection of invention patent application after publication |